Screener
Eligibility screening
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
3 US sites in TX
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
3 US sites in TX
Before we begin
Your answer affects how the questions are phrased.